News for 'diabetes'

'Diabetes Is Not A Disease, It Is Only A Disorder. So, Don't Panic'

'Diabetes Is Not A Disease, It Is Only A Disorder. So, Don't Panic'

Rediff.com5 days ago

'Control your A, B, C and D.' 'A is A1C, keep your A1C below 7 per cent.' 'B is blood pressure, so keep your blood pressure at 130/ 80 or at least below 140/ 90.' 'C is cholesterol. The bad cholesterol is the LDL cholesterol, and it should be kept below 100, preferably below 70 or 50.' 'D is discipline like diet, exercise, sleep, no smoking, etc.' 'People with diabetes who follow A, B, C and D can live up to even 100 years of age without any complications.'

Novo Nordisk introduces 'Awiqli', a once-weekly insulin injection for diabetes in India

Novo Nordisk introduces 'Awiqli', a once-weekly insulin injection for diabetes in India

Rediff.com9 Jul 2026

Danish pharma major Novo Nordisk has launched 'Awiqli' in India, a once-weekly basal insulin injection for adults with diabetes, aiming to simplify treatment and reduce the burden of daily injections.

Gurugram Busts Racket Making Fake Diabetes Injections

Gurugram Busts Racket Making Fake Diabetes Injections

Rediff.com21 Apr 2026

Authorities in Gurugram have uncovered a racket involved in the manufacturing and sale of fake Mounjaro (tirzepatide) injections, used for treating diabetes and obesity. Two people have been arrested, and a nationwide alert has been issued to trace counterfeit batches.

Infection risk looms large as CJP protesters fall ill

Infection risk looms large as CJP protesters fall ill

Rediff.com3 days ago

Protesters at Jantar Mantar are facing significant health challenges due to scorching heat, high humidity, and overcrowding, leading to widespread viral infections, dehydration, and injuries. Volunteer doctors are providing essential medical care amidst these difficult conditions.

0%, 100%, 200%: Trump's new generic drug tariff may hit India

0%, 100%, 200%: Trump's new generic drug tariff may hit India

Rediff.com6 days ago

US President Donald Trump announced steep tariffs on imported generic medicines, effective from August 2028, with the aim of boosting domestic pharmaceutical production. This policy, which includes a phased increase in tariffs up to 200 per cent, could significantly impact India, a major global supplier of generic drugs to the US market.

Gurugram Police Uncover Fake Diabetes Injection Racket

Gurugram Police Uncover Fake Diabetes Injection Racket

Rediff.com21 Apr 2026

Authorities in Gurugram have uncovered a racket involving the manufacturing and sale of counterfeit Mounjaro (tirzepatide) injections, used for treating type 2 diabetes and aiding weight loss. Two individuals have been arrested, and a nationwide alert has been issued to detect the fake injections.

Gurugram Police Uncover Fake Diabetes Drug Racket

Gurugram Police Uncover Fake Diabetes Drug Racket

Rediff.com20 Apr 2026

Authorities in Gurugram have uncovered a racket involving the manufacturing and sale of counterfeit Mounjaro (tirzepatide) injections, used for treating type 2 diabetes and aiding weight loss, leading to the arrest of two individuals and a nationwide alert.

19th maternal death in Rajasthan as woman dies post-Caesarean

19th maternal death in Rajasthan as woman dies post-Caesarean

Rediff.com15 Jul 2026

A 25-year-old woman's death at Bikaner's PBM Hospital due to post-Caesarean complications marks the third such fatality at the facility and brings Rajasthan's maternal death toll to 19 in three months. The state government has launched a five-day campaign to screen all pregnant women to address the rising mortality rate.

Why You MUST Check Your Blood Pressure Regularly

Why You MUST Check Your Blood Pressure Regularly

Rediff.com13 Jul 2026

Young adults in India are increasingly grappling with high blood pressure, a condition once thought to affect mainly the older demographics. Cardiologists point to sedentary lifestyles, obesity, chronic stress and unhealthy diets as primary drivers of this silent epidemic.

Study: Smartwatch Data Offers Scalable Way to Detect Early Diabetes Risk

Study: Smartwatch Data Offers Scalable Way to Detect Early Diabetes Risk

Rediff.com18 Mar 2026

A new study reveals a framework using smartwatch data to detect early signs of diabetes by predicting insulin resistance, potentially enabling timely lifestyle interventions.

Think Tank Calls For Probe Into Fake Diabetes Drug Racket

Think Tank Calls For Probe Into Fake Diabetes Drug Racket

Rediff.com22 Apr 2026

An independent think tank on policing has called for a multi-agency investigation into the recent unearthing of a spurious Mounjaro (tirzepatide) injection manufacturing racket in Gurugram, offering free-of-cost forensic expertise.

Psychological Stress Linked To Gut Microbiome Changes And Health Risks

Psychological Stress Linked To Gut Microbiome Changes And Health Risks

Rediff.com3 Jul 2026

A new study in mice reveals that psychological stress can significantly alter the gut microbiome, leading to changes in blood-forming stem cells and increasing the risk of conditions like heart disease and diabetes. Researchers found that stress impacts specific brain regions, which in turn affect intestinal microbiota balance and hematopoietic stem cell function.

Breakthrough: Indian Researchers Create Placenta-On-Chip For Pregnancy Study

Breakthrough: Indian Researchers Create Placenta-On-Chip For Pregnancy Study

Rediff.com4 Jul 2026

Indian researchers from ICMR-National Institute for Research on Women's Health and IIT Bombay have developed an indigenous "placenta-on-chip" platform. This microphysiological system mimics the human placental barrier, reproducing essential functions like hormone production and nutrient transfer. It offers a simple, scalable tool for studying placental biology, pregnancy complications, and drug effects, aiming to reduce reliance on animal experimentation.

World IVF Day: 10 Habits That Lower Sperm Count

World IVF Day: 10 Habits That Lower Sperm Count

Rediff.com3 days ago

From what goes on your plate to how long someone sits with a laptop on their lap, seemingly harmless habits can make a big difference, warns says Dr Aakil Khan, consultant and urologist at KIMS Hospitals, Thane.

Diabetics Can Eat Fruits But....

Diabetics Can Eat Fruits But....

Rediff.com16 Jan 2026

rediffGURU Komal Jethmalani, a nutritionist with nearly three decades of experience, suggests how to make the right diet and lifestyle choices to keep blood sugar under check.

Inside Alexander Zverev's quiet battle with diabetes

Inside Alexander Zverev's quiet battle with diabetes

Rediff.com26 Jan 2026

As he chases Grand Slam success, Alexander Zverev describes the unseen routines and discipline behind playing tennis with type 1 diabetes.

'Indians Have The Worst Metabolism, Diets High In Refined Carbs'

'Indians Have The Worst Metabolism, Diets High In Refined Carbs'

Rediff.com8 Jun 2026

'Refined carbohydrates are the quiet troublemaker in our diet.' 'We eat plenty of calories, but not enough nutrition.'

Andhra Covid Deaths Trigger Southern Alert

Andhra Covid Deaths Trigger Southern Alert

Rediff.com15 Jul 2026

'There is no need for panic as there is widespread protective immune memory in the population from vaccination as well as prior infections.'

One In Three Indian Women Overweight

One In Three Indian Women Overweight

Rediff.com9 Jun 2026

Over the past year, the sale of injectable GLP-1 agonists (used to treat type 2 diabetes and obesity) such as Mounjaro, Wegovy and Ozempic have surged a whopping 218 per cent.

Antibiotic Resistance Threatens Safe Surgery

Antibiotic Resistance Threatens Safe Surgery

Rediff.com15 Jul 2026

'As bacteria become increasingly resistant, preserving the effectiveness of existing antibiotics is everyone's responsibility.'

Experts question relying solely on HbA1c for diabetes test

Experts question relying solely on HbA1c for diabetes test

Rediff.com10 Feb 2026

Researchers are cautioning against relying solely on glycated haemoglobin (HbA1c) for diagnosing and monitoring diabetes in South Asia, especially India, due to the high prevalence of anaemia and blood disorders that can complicate the interpretation of values.

Biocon launches diabetes & obesity drugs in Netherlands

Biocon launches diabetes & obesity drugs in Netherlands

Rediff.com16 Dec 2025

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the fast-growing diabetes and obesity market currently dominated by the likes of Novo Nordisk and Eli Lilly.

10 Questions Every First-Time Health Insurance Buyer Must Ask

10 Questions Every First-Time Health Insurance Buyer Must Ask

Rediff.com7 Jul 2026

The best time to buy health insurance is when you don't think you need it.

'1.38L CCTVs, 51k jammers': Over 2.8L students to take NEET re-exam amid tight security

'1.38L CCTVs, 51k jammers': Over 2.8L students to take NEET re-exam amid tight security

Rediff.com20 Jun 2026

The National Testing Agency (NTA) has implemented extensive security and logistical arrangements, including AI-based CCTV monitoring, biometric verification, and police escorts, to ensure the smooth, secure, and transparent conduct of the NEET-UG 2026 re-examination.

'No Such Thing As Diabetes Reversal'

'No Such Thing As Diabetes Reversal'

Rediff.com14 Nov 2025

'In diabetes remission, you go below a 6.5 HbA1c without medication.' 'And this happens only when you lose 10 to 15 per cent of your body weight with a good amount of lifestyle and dietary changes, exercise and sometimes medication.' 'You have to be able to sustain your HBA1C below 6.5 for at least a year without medication to say that the patient is in remission.'

Experts Call For National Policy To Boost Assistive Technology Market

Experts Call For National Policy To Boost Assistive Technology Market

Rediff.com24 Jun 2026

Experts highlight India's significant market potential for assistive technologies, estimated at Rs 75,000-95,000 crore by 2030. They advocate for a National Assistive Technology Policy to address current gaps in access and service delivery, fostering inclusion, independence, and economic participation for persons with disabilities and the elderly.

What Is Primary Ovarian Insufficiency (POI)?

What Is Primary Ovarian Insufficiency (POI)?

Rediff.com25 Jun 2026

Gynaecologists are noticing a gradual rise in POI cases, with a few women under 40 being diagnosed every month.

Air India introduces basic fare category without complimentary meals

Air India introduces basic fare category without complimentary meals

Rediff.com17 Jun 2026

Loss-making Air India has introduced a new 'Basic Fare' category for select domestic flights, which does not include complimentary meals, as part of its efforts to trim expenses amid rising operational costs.

Countdown to NEET re-exam: NTA to hold nationwide mock drill on Saturday

Countdown to NEET re-exam: NTA to hold nationwide mock drill on Saturday

Rediff.com19 Jun 2026

The National Testing Agency (NTA) will conduct a nationwide mock drill on Saturday ahead of the NEET-UG re-examination the day after as part of its preparations to ensure the smooth, secure and transparent conduct of the test, official said on Friday.

A Green Banana Adventure

A Green Banana Adventure

Rediff.com23 Jun 2026

It took years and years to bump into a green banana and learn how to eat it.

Mumbai Court Denies Bail To 71-Year-Old In Land Fraud Case

Mumbai Court Denies Bail To 71-Year-Old In Land Fraud Case

Rediff.com8 Jun 2026

A Mumbai court has refused bail to 71-year-old Prakash Dubey, who is accused of illegally acquiring 12,550 square metres of land using counterfeit government stamps and a forged power of attorney. The court cited the seriousness of the allegations and the ongoing investigation, stating that Dubey's age and medical conditions did not outweigh the gravity of the crime.

Canada first G7 nation to okay Dr Reddy's generic version of semaglutide

Canada first G7 nation to okay Dr Reddy's generic version of semaglutide

Rediff.com30 Apr 2026

Dr Reddy's Laboratories has received approval from Health Canada to sell a generic version of the diabetes drug semaglutide, making it the first company to get market authorisation for a generic semaglutide injection in Canada and the first in a G7 country.

Want To Be A Mounjaro Bride: Is It Worth It?

Want To Be A Mounjaro Bride: Is It Worth It?

Rediff.com26 May 2026

'Don't chase unrealistic expectations or compare yourself to social media transformations.' 'Focus on your health first, not just the number on the scale before the wedding.'

AIIMS Delhi Achieves Rare Pancreas-Kidney Transplant After 18 Years

AIIMS Delhi Achieves Rare Pancreas-Kidney Transplant After 18 Years

Rediff.com13 May 2026

Doctors at AIIMS, Delhi, have successfully performed a simultaneous pancreas-kidney transplant after 18 years, marking a significant advancement in organ transplantation in India. The surgery was performed on a 30-year-old patient with end-stage renal disease caused by Type 1 diabetes.

'Every Other Person Could Have Diabetes'

'Every Other Person Could Have Diabetes'

Rediff.com12 Nov 2025

'One in two people tested shows high blood sugar levels.' '51.9 per cent of men and 45.43 per cent of women who tested had high blood sugar.'

Thousands Of Weight Loss Injections Seized In Gurugram

Thousands Of Weight Loss Injections Seized In Gurugram

Rediff.com19 Apr 2026

A vehicle carrying thousands of weight loss and diabetes injections was seized in Gurugram during a raid by the Drug Control Department.

Weight Loss Drugs Sales Surge!

Weight Loss Drugs Sales Surge!

Rediff.com16 May 2026

'The innovators have been able to more or less stay where they are, in terms of revenue even as the generics are seeing exponential growth due to their affordability.'

Pune Firm Unveils Diabetes-Control Implant

Pune Firm Unveils Diabetes-Control Implant

Rediff.com19 Nov 2025

This innovation works by stimulating our natural organs so that it can produce and maintain the insulin balance.

Slimming Drug Boom Sparks Misuse Concerns: 'They Are Not Meant For Cosmetic Weight Loss'

Slimming Drug Boom Sparks Misuse Concerns: 'They Are Not Meant For Cosmetic Weight Loss'

Rediff.com20 Apr 2026

The fast-growing GLP-1 market, propelled by lower-cost generics following patent expiry, is widening availability beyond patients with obesity and diabetes -- but also driving unsupervised, appearance-led demand, according to doctors.

Weight Loss Drugs May Alter Your Brain

Weight Loss Drugs May Alter Your Brain

Rediff.com12 May 2026

A new study suggests that newer oral weight loss drugs may do more than suppress appetite, potentially altering brain circuits that control motivation and reward, impacting how one experiences pleasure.